PODUSMA Trademark
Trademark Overview
On Tuesday, November 22, 2022, a trademark application was filed for PODUSMA with the United States Patent and Trademark Office. The USPTO has given the PODUSMA trademark a serial number of 97687709. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, April 11, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The PODUSMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive prepa...
General Information
| Serial Number | 97687709 |
| Word Mark | PODUSMA |
| Filing Date | Tuesday, November 22, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Friday, April 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 12, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
Trademark Events
| Event Date | Event Description |
| Monday, August 7, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 25, 2022 | NEW APPLICATION ENTERED |
| Friday, November 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 1, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, August 23, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 12, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, April 25, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, April 25, 2024 | SOU EXTENSION 1 FILED |
| Thursday, April 25, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, April 26, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 29, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, October 29, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, April 11, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 11, 2025 | SOU EXTENSION 3 FILED |
| Friday, April 11, 2025 | SOU EXTENSION 3 GRANTED |
| Saturday, April 12, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
